Telehealth future, Expanded Prolia, BioCeuticals upgrade, Nurofen controversy and much more…
Click here to download Pharmacy Daily for Thursday 9th August 2012
PARTNER SITES
Other recent headlines
-
BCNA urges swift action
Monday | Apr 29 2024BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
-
Bol to speak at PC2024
Monday | Apr 29 2024PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
-
WA group stocks vapes
Friday | Apr 26 2024IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
to top